The investment seeks daily investment results before fees and expenses that correspond to twice (2x) the daily performance of the index.


Updates from The Motley Fool

Latest updates on ProShares Ultra Nasdaq Biotechnology from Fool.com.

There is no available coverage of ProShares Ultra Nasdaq Biotechnology at this time.



Stock Performance

BIB vs. S&P 500 | 2 Year Performance
View Interactive BIB Charts
Sponsored by

Key Data Points

Primary metrics and data points about ProShares Ultra Nasdaq Biotechnology.
Current Price: $38.42
Prev Close: $36.84
Open: $37.60
Bid: $38.15
Ask: $38.75
Day's Range: $37.26 - $38.83
52wk Range: $35.23 - $106.10
Volume: 725,348
Avg Vol 610,901
Market Cap: $403.41M
P/E (ttm): 0.00
EPS (ttm): $0.00
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about ProShares Ultra Nasdaq Biotechnology.
CAPS Rating 2 out of 5
 
72 Outperform
44 Underperform
CAPS All Stars
 
24 Outperform
20 Underperform

How do you think ProShares Ultra Nasdaq Biotechnology will perform against the market?



You pick for ProShares Ultra Nasdaq Biotechnology is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


Business Summary

Industry, sector and description for ProShares Ultra Nasdaq Biotechnology.

The investment seeks daily investment results before fees and expenses that correspond to twice (2x) the daily performance of the index.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Medical Supply